These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 8915711)

  • 1. Serum biochemical markers of bone turnover in healthy infants and children.
    Tommasi M; Bacciottini L; Benucci A; Brocchi A; Passeri A; Saracini D; D'Agata A; Cappelli G
    Int J Biol Markers; 1996; 11(3):159-64. PubMed ID: 8915711
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prediction of bone mass in renal hyperparathyroidism by newly developed bone metabolic markers: evaluation of serum levels of carboxy-terminal pyridinoline cross-linked telopeptide of type I collagen and carboxy-terminal propeptide of type I procollagen.
    Katagiri M; Fukunaga M; Ohtawa T; Harada T
    World J Surg; 1996 Sep; 20(7):753-6; discussion 756-7. PubMed ID: 8678946
    [TBL] [Abstract][Full Text] [Related]  

  • 3. A cross-sectional study on biochemical parameters of bone turnover and vitamin d metabolites in healthy dutch children and young adults.
    van der Sluis IM; Hop WC; van Leeuwen JP; Pols HA; de Muinck Keizer-Schrama SM
    Horm Res; 2002; 57(5-6):170-9. PubMed ID: 12053089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Bone turnover in children with vitamin D deficiency rickets before and during treatment.
    Baroncelli GI; Bertelloni S; Ceccarelli C; Amato V; Saggese G
    Acta Paediatr; 2000 May; 89(5):513-8. PubMed ID: 10852183
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sex- and age-specific reference curves for serum markers of bone turnover in healthy children from 2 months to 18 years.
    Rauchenzauner M; Schmid A; Heinz-Erian P; Kapelari K; Falkensammer G; Griesmacher A; Finkenstedt G; Högler W
    J Clin Endocrinol Metab; 2007 Feb; 92(2):443-9. PubMed ID: 17105843
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Changes in bone turnover after parathyroidectomy in dialysis patients: role of calcitriol administration.
    Mazzaferro S; Chicca S; Pasquali M; Zaraca F; Ballanti P; Taggi F; Coen G; Cinotti GA; Carboni M
    Nephrol Dial Transplant; 2000 Jun; 15(6):877-82. PubMed ID: 10831645
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Dose-dependent effects of recombinant human growth hormone on biochemical markers of bone and collagen metabolism in adult growth hormone deficiency.
    Bollerslev J; Møller J; Thomas S; Djøseland O; Christiansen JS
    Eur J Endocrinol; 1996 Dec; 135(6):666-71. PubMed ID: 9025710
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Serum interleukin-6 in renal osteodystrophy: relationship with serum PTH and bone remodeling markers.
    Montalbán C; García-Unzueta MT; De Francisco AL; Amado JA
    Horm Metab Res; 1999 Jan; 31(1):14-7. PubMed ID: 10077343
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The effect of intermittent slow-release sodium fluoride and continuous calcium citrate therapy on calcitropic hormones, biochemical markers of bone metabolism, and blood chemistry in postmenopausal osteoporosis.
    Zerwekh JE; Padalino P; Pak CY
    Calcif Tissue Int; 1997 Oct; 61(4):272-8. PubMed ID: 9312196
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Serum levels of the pyridinoline crosslinked carboxyterminal telopeptide of type I collagen (ICTP) and osteocalcin in rachitic children in Nigeria.
    Scariano JK; Walter EA; Glew RH; Hollis BW; Henry A; Ocheke I; Isichei CO
    Clin Biochem; 1995 Oct; 28(5):541-5. PubMed ID: 8582054
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Reference database of biochemical markers of bone turnover for the Japanese female population. Japanese Population-based Osteoporosis (JPOS) Study.
    Iki M; Akiba T; Matsumoto T; Nishino H; Kagamimori S; Kagawa Y; Yoneshima H;
    Osteoporos Int; 2004 Dec; 15(12):981-91. PubMed ID: 15570414
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Biochemical parameters of bone turnover in kidney transplant recipients.
    Smalcelj R; Kusec V; Puretić Z; Mareković Z
    Wien Klin Wochenschr; 1998 May; 110(9):326-30. PubMed ID: 9629624
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Changes of bone markers during long-term intravenous calcitriol therapy in maintenance dialysis patients.
    Lee SH; Huang TS; Hsieh SJ
    Miner Electrolyte Metab; 1996; 22(4):219-23. PubMed ID: 8807625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in bone mass and serum markers of bone metabolism after parathyroidectomy.
    Thorsen K; Kristoffersson AO; Lorentzon RP
    Surgery; 1997 Nov; 122(5):882-7. PubMed ID: 9369887
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Procollagen I carboxyterminal propeptide (PICP) as a bone formation marker and carboxyterminal telopeptide of type I collagen (ICTP) as a bone degradation marker in children with chronic renal failure under conservative therapy.
    Polak-Jonkisz D; Zwolińska D; Bednorz R; Owczarek H; Szymańska A; Nahaczewska W
    Med Sci Monit; 2003 Jan; 9(1):CR19-23. PubMed ID: 12552245
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bone turnover is reduced in children with juvenile rheumatoid arthritis.
    Falcini F; Ermini M; Bagnoli F
    J Endocrinol Invest; 1998 Jan; 21(1):31-6. PubMed ID: 9633020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Serum osteocalcin and bone alkaline phosphatase in healthy children in relation to age and gender].
    Ambroszkiewicz J; Gajewska J; Laskowska-Klita T
    Med Wieku Rozwoj; 2002; 6(3):257-65. PubMed ID: 12637780
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of 12 months of recombinant growth hormone therapy on parameters of bone metabolism and bone mineral density in patients on chronic hemodialysis.
    Kotzmann H; Riedl M; Pietschmann P; Schmidt A; Schuster E; Kreuzer S; Kainberger F; Frisch H; Geyer G; Hörl WH; Mayer G; Luger A
    J Nephrol; 2004; 17(1):87-94. PubMed ID: 15151263
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Biochemical markers of bone formation activity in children with neoplasms].
    Muszyńska-Rosłan K; Krawczuk-Rybak M; Protas P; Siedlecka E; Wiśniewska M; Wołczyński S
    Wiad Lek; 2005; 58(1-2):29-35. PubMed ID: 15991550
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Characteristics of biochemical markers in patients with metabolic bone disorders.
    Hoshino H; Kushida K; Takahashi M; Kawana K; Denda M; Yamazaki K; Inoue T
    Endocr Res; 1998 Feb; 24(1):55-64. PubMed ID: 9553754
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.